GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr Lalchandani Labs Ltd (BOM:541299) » Definitions » Gross Profit

Dr Lalchandani Labs (BOM:541299) Gross Profit : ₹27.55 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Dr Lalchandani Labs Gross Profit?

Dr Lalchandani Labs's gross profit for the six months ended in Mar. 2024 was ₹13.10 Mil. Dr Lalchandani Labs's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was ₹27.55 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Dr Lalchandani Labs's gross profit for the six months ended in Mar. 2024 was ₹13.10 Mil. Dr Lalchandani Labs's Revenue for the six months ended in Mar. 2024 was ₹20.83 Mil. Therefore, Dr Lalchandani Labs's Gross Margin % for the quarter that ended in Mar. 2024 was 62.90%.

Dr Lalchandani Labs had a gross margin of 62.90% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 12 years, the highest Gross Margin % of Dr Lalchandani Labs was 88.43%. The lowest was 46.32%. And the median was 68.36%.

Warning Sign:

Dr Lalchandani Labs Ltd gross margin has been in long-term decline. The average rate of decline per year is -6.1%.


Dr Lalchandani Labs Gross Profit Historical Data

The historical data trend for Dr Lalchandani Labs's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Lalchandani Labs Gross Profit Chart

Dr Lalchandani Labs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.54 61.71 83.04 38.25 27.55

Dr Lalchandani Labs Semi-Annual Data
Mar13 Mar14 Mar15 Mar16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.59 16.09 22.16 14.44 13.10

Competitive Comparison of Dr Lalchandani Labs's Gross Profit

For the Diagnostics & Research subindustry, Dr Lalchandani Labs's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Lalchandani Labs's Gross Profit Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr Lalchandani Labs's Gross Profit distribution charts can be found below:

* The bar in red indicates where Dr Lalchandani Labs's Gross Profit falls into.



Dr Lalchandani Labs Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Dr Lalchandani Labs's Gross Profit for the fiscal year that ended in Mar. 2024 is calculated as

Gross Profit (A: Mar. 2024 )=Revenue - Cost of Goods Sold
=48.094 - 20.549
=27.55

Dr Lalchandani Labs's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=20.833 - 7.729
=13.10

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹27.55 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Dr Lalchandani Labs's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=13.10 / 20.833
=62.90 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Dr Lalchandani Labs  (BOM:541299) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Dr Lalchandani Labs had a gross margin of 62.90% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Dr Lalchandani Labs Gross Profit Related Terms

Thank you for viewing the detailed overview of Dr Lalchandani Labs's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr Lalchandani Labs (BOM:541299) Business Description

Traded in Other Exchanges
N/A
Address
Greater Kailash, Part-1, M-20, Basement, South Delhi, New Delhi, IND, 110048
Dr Lalchandani Labs Ltd engages in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations. It also offers Immunoassay, Immuno-Histochemistry, Molecular Pathology, DNA, and Genetic Testing. The company operates in two segments B2B sales and B2C sales, out of which the majority is from B2C sales. Revenue is generated from the sale of services.

Dr Lalchandani Labs (BOM:541299) Headlines

No Headlines